Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Revenue (2017 - 2025)

Historic Revenue for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $150.9 million.

  • Organogenesis Holdings' Revenue rose 3098.45% to $150.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $465.2 million, marking a year-over-year increase of 223.72%. This contributed to the annual value of $482.0 million for FY2024, which is 1129.03% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Revenue of $150.9 million as of Q3 2025, which was up 3098.45% from $101.0 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Revenue ranged from a high of $150.9 million in Q3 2025 and a low of $86.7 million during Q1 2025
  • In the last 5 years, Organogenesis Holdings' Revenue had a median value of $115.2 million in 2024 and averaged $114.3 million.
  • Per our database at Business Quant, Organogenesis Holdings' Revenue skyrocketed by 7864.85% in 2021 and then tumbled by 2244.34% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Revenue (Quarter) stood at $127.9 million in 2021, then fell by 9.65% to $115.5 million in 2022, then decreased by 13.73% to $99.7 million in 2023, then increased by 27.1% to $126.7 million in 2024, then grew by 19.11% to $150.9 million in 2025.
  • Its last three reported values are $150.9 million in Q3 2025, $101.0 million for Q2 2025, and $86.7 million during Q1 2025.